Effect of induced hypoalbuminemia on distribution, total clearance and unbound clearance of piroxicam in vivo in the rat
- PMID: 8243500
- DOI: 10.1007/BF03188792
Effect of induced hypoalbuminemia on distribution, total clearance and unbound clearance of piroxicam in vivo in the rat
Abstract
The influence of decreased albumin concentration on the pharmacokinetic behaviour of Piroxicam was studied in vivo in rats that had undergone plasmapheresis. Reductions of approximately 25% and 50% in the plasma albumin concentration were achieved, the former in rats not given plasma expander, the latter in animals given Ficol-70 as a plasma expander. The unbound fraction of Piroxicam in plasma and the apparent volume of distribution at steady state experienced a statistically significant increase where the albumin concentration was reduced. The average total plasma clearance rose with the increase in fu, between the control (6.3 +/- 2.4 ml/h) and plasmapheretic groups (11.1 +/- 4 ml/h), in accordance with predictions of the 'well-stirred' and 'parallel-tube' models, but no statistically significant differences were found between the two groups, perhaps because of the great interindividual variability associated with this parameter. The total plasma clearance value of the Ficol group (5.4 +/- 2.2 ml/h) was close to that of the control group, despite the high increase in the unbound fraction in plasma. Alterations in the uptake process in the liver due to the high level of induced hypoalbuminemia may have occurred.
Similar articles
-
Effect of uraemia and anephric state on the pharmacokinetics of tenoxicam in the rat.J Pharm Pharmacol. 1992 Nov;44(11):898-901. doi: 10.1111/j.2042-7158.1992.tb03232.x. J Pharm Pharmacol. 1992. PMID: 1361533
-
Effect of altered albumin concentrations on elimination of unbound prazosin in vivo in the rat and in the isolated perfused rat liver.J Pharm Sci. 1988 Nov;77(11):948-51. doi: 10.1002/jps.2600771110. J Pharm Sci. 1988. PMID: 3225755
-
Tenoxicam pharmacokinetics in rats: a population model.J Pharm Sci. 1995 Dec;84(12):1482-7. doi: 10.1002/jps.2600841216. J Pharm Sci. 1995. PMID: 8748332
-
Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents.Clin Pharmacokinet. 1994 Feb;26(2):107-20. doi: 10.2165/00003088-199426020-00004. Clin Pharmacokinet. 1994. PMID: 8162655 Review.
-
Protein binding in antiretroviral therapies.AIDS Res Hum Retroviruses. 2003 Sep;19(9):825-35. doi: 10.1089/088922203769232629. AIDS Res Hum Retroviruses. 2003. PMID: 14585213 Review.
Cited by
-
Multi-phase multi-layer mechanistic dermal absorption (MPML MechDermA) model to predict local and systemic exposure of drug products applied on skin.CPT Pharmacometrics Syst Pharmacol. 2022 Aug;11(8):1060-1084. doi: 10.1002/psp4.12814. Epub 2022 Jun 27. CPT Pharmacometrics Syst Pharmacol. 2022. PMID: 35670226 Free PMC article.
-
Alterations in cefalosporin levels in the serum and mandible of hyperlipaedemic rats after co-administration of ibuprofen.Eur J Drug Metab Pharmacokinet. 2005 Jul-Sep;30(3):171-4. doi: 10.1007/BF03190616. Eur J Drug Metab Pharmacokinet. 2005. PMID: 16250253
-
A Physiologically Based Pharmacokinetic Perspective on the Clinical Utility of Albumin-Based Dose Adjustments in Critically Ill Patients.Clin Pharmacokinet. 2018 Jan;57(1):59-69. doi: 10.1007/s40262-017-0549-x. Clin Pharmacokinet. 2018. PMID: 28497260